Collinsworth spent eight seasons in the NFL as a wide receiver for the Cincinnati Bengals. He was a three-time Pro Bowler, ...

It’s just the latest landmark for Indianapolis-based Lilly, which was catapulted into the top spot as the world’s largest ...

Oliver Barnes Pfizer and Novo Nordisk duked it out for who will own Metsera — a coveted biotech that’s developing ...

A nalysts at Wall Street firm Bernstein have raised their price target on Eli Lilly’s (LLY) stock to $1,300 from $1,100 and ...

With promising new obesity treatments in the pipeline, 24/7 Wall St. projects huge upside for Novo Nordisk stock through 2030 ...

Broadcom’s custom AI chips have become increasingly important to Alphabet in the rollout of Gemini 3, which has been trained ...

​Novo Nordisk A/S (NYSE: NVO) is one of the Most Profitable Stocks to Buy Now. On November 17, Reuters reported that Novo ...

European Union officials may cut growth forecasts for 2026 in the coming week in an assessment of damage to the region’s ...

The daily pill may provide a more convenient alternative to injections, which patients can find difficult to administer.

A new oral GLP-1 medication can help adults with obesity and type 2 diabetes lose more weight and improve their blood sugar ...

Novo Nordisk said on Monday it would lower the U.S. price of its injectable Wegovy obesity drug and pledged to go "all in" on its upcoming oral weight-loss pill, as the firm races to claw back lost ...

Oral weight-loss pills will be replacing GLP-1 shots by March 2026, Medicare and Medicaid Services Administrator Dr. Mehmet Oz predicted on Monday. Oz made the statement during a Monday morning ...